References
- Ashare, R. L., Baschnagel, J. S., & Hawk, L. W. (2010). Subjective effects of transdermal nicotine among nonsmokers. Experimental and Clinical Psychopharmacology, 18(2), 167–174. https://doi.org/10.1037/a0018864
- Dale, L. C., Hurt, R. D., Offord, K. P., Lawson, G. M., Croghan, I. T., & Schroeder, D. R. (1995). High-dose nicotine patch therapy. Percentage of Replacement and Smoking Cessation JAMA, 274(17), 1353–1358. https://doi.org/10.1001/jama.274.17.1353
- de Wit, H., & Zacny, J. (1995). Abuse potential of nicotine replacement therapies. CNS Drugs, 4(6), 456–468. https://doi.org/10.2165/00023210-199504060-00008
- Ebbert, J. O., Dale, L. C., Patten, C. A., Croghan, I. T., Schroeder, D. R., Moyer, T. P., & Hurt, R. D. (2007). Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine & Tobacco Research, 9(1), 43–52. https://doi.org/10.1080/14622200601078285
- Henningfield, J. E., & Keenan, R. M. (1993). Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychology, 61(5), 743–750. https://doi.org/10.1037/0022-006X.61.5.743
- Hurt, R. D., Dale, L. C., Offord, K. P., Lauger, G. G., Baskin, L. B., Lawson, G. M., Jiang, N. S., & Hauri, P. J. (1993). Serum nicotine and cotinine levels during nicotine-patch therapy. Clinical Pharmacology and Therapeutics, 54(1), 98–106. https://doi.org/10.1038/clpt.1993.117
- Jorenby, D. E., Smith, S. S., Fiore, M. C., Hurt, R. D., Offord, K. P., Croghan, I. T., Hays, J. T., Lewis, S. F., & Baker, T. B. (1995). Varying nicotine patch dose and type of smoking cessation counseling. Journal of American Medical Association, 274(17), 1347–1352. https://doi.org/10.1001/jama.1995.03530170027027
- Montalto, N., Brackett, C. C., & Sobol, T. (1994). Use of transdermal nicotine systems in a possible suicide attempt. Journal of American Board of Family Practice, 7(5), 417–420.
- Perkins, K. A., Jetton, C., & Keenan, J. (2003). Common factors across acute subjective effects of nicotine. Nicotine & Tobacco Research, 5(6), 869–875. https://doi.org/10.1080/14622200310001614629
- Pickworth, W. B., Bunker, E. B., & Henningfield, J. E. (1994). Transdermal nicotine: Reduction of smoking with minimal abuse liability. Psychopharmacology, 115(1–2), 9–14. https://doi.org/10.1007/BF02244745
- Przulj, D., Wehbe, L., McRobbie, H., & Hajek, P. (2019). Progressive nicotine patch dosing prior to quitting smoking: Feasibility, safety and effects during the pre-quit and post-quit periods. Addiction, 114(3), 515–522. https://doi.org/10.1111/add.14483
- Shiffman, S., Ferguson, S. G., Gwaltney, C. J., Balabanis, M. H., & Shadel, W. G. (2006). Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology, 184(3–4), 637–644. https://doi.org/10.1007/s00213-005-0184-3
- Tjoncke, J. A., Goncalves, R., Castaing, N., Molimard, M., Tovagliaro, F., & Titier, K. (2020). Death related to nicotine replacement therapy: A case report. Forensic Science International, 309, 110223. https://doi.org/10.1016/j.forsciint.2020.110223
- West, R., Hajek, P., Foulds, J., Nilsson, F., May, S., & Meadows, A. (2000). A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology, 149(3), 198–202. https://doi.org/10.1007/s002130000382
- Woolf, A., Burkhart, K., Caraccio, T., & Litovitz, T. (1996). Self-poisoning among adults using multiple transdermal nicotine patches. Journal of Toxicology: Clinical Toxicology, 34(6), 691–698. https://doi.org/10.3109/15563659609013830